Boots is to start prescribing medical cannabis, it has announced, in a first for a UK high street pharmacy.The online service is being offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.The chain is launching its SureLeaf service alongside a collaborative research programme with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.Patients will be invited to start an assessment online. Their suitability will then be reviewed by a clinical team, before they are invited to a video consultation with a consultant, according to Boots.Boots said any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins”. It said any patient wishing to be prescribed medical cannabis must first have tried conventional treatments without success. And the pharmacy said patients would be regularly reviewed.Boots’ chief healthcare officer, Jamie Kerruish, said: “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.“Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.”Dr David Gwynne, the medical director of Boots’ online service, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.“SureLeaf has, therefore, been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate. Our priority is to ensure patients receive responsible, clinically led care, from their initial specialist assessment through to ongoing monitoring and review once treatment begins.”The prescription of cannabis-derived medicines was legalised in 2018 after the mother of a young boy from Northern Ireland with severe epilepsy had cannabis oil seized at airport customs. Many private clinics have been treating patients with them for years.skip past newsletter promotionafter newsletter promotionHopes have been expressed that cannabis could revolutionise some areas of medicine. Only people with rare forms of epilepsy, those dealing with certain side-effects of chemotherapy, and those with certain multiple sclerosis symptoms, can get it on the NHS. But, besides chronic pain, private clinics have also been prescribing the medicines for various psychiatric disorders and neurological conditions.This year, researchers from universities in Sydney, Brisbane and Melbourne in Australia, and Bath in England, found “very little evidence” that cannabis was effective in treating anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder or opioid use disorder.They found some evidence the medical products could reduce dependence on cannabis, relieve the symptoms of Tourette syndrome and help insomniacs sleep better.
Boots to begin prescribing medical cannabis in UK
Full Article
Original Source
Read the full article at Theguardian →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.